UDIMAX-150: Essential Care for Liver and Gallbladder Health

Click Healthcare proudly offers UDIMAX-150 (Ursodeoxycholic Acid IP 150mg Tablets), a vital allopathic medication within the Hepatoprotective segment. This formulation is primarily indicated for the management of cholesterol-rich gallstones and the treatment of Primary Biliary Cirrhosis (PBC), a chronic liver disease. By providing essential support to the biliary system and liver function, UDIMAX-150 helps patients manage complex gastrointestinal and hepatic disorders, offering a crucial non-surgical alternative for select conditions.

The therapeutic effectiveness of UDIMAX-150 is centered on its active ingredient, Ursodeoxycholic Acid (UDCA), a naturally occurring bile acid. UDCA works by actively reducing the cholesterol saturation in the bile, which, over time, helps to dissolve existing cholesterol gallstones. Furthermore, as a hepatoprotective agent, it shields liver cells from the toxic effects of accumulated bile acids, promoting better bile flow and improving overall liver enzyme levels and function, which is critical in managing progressive diseases like PBC.

Manufactured and distributed through the trusted Click Healthcare PCD Pharma Franchise Division of MK Healthcare, UDIMAX-150 adheres to rigorous pharmaceutical quality standards. Our commitment to efficacy and patient safety ensures that this high-demand medication is a reliable choice for specialists in gastroenterology and hepatology. The 150mg strength is precisely formulated to initiate and sustain the necessary therapeutic action for long-term liver and gallbladder health management.

For pharmaceutical partners and distributors, UDIMAX-150 represents an essential inclusion in the Gastro/Hepatology product line, backed by the quality assurance of MK Healthcare. Given the increasing prevalence of liver and gallbladder disorders, this product offers a significant market opportunity. We invite you to explore franchise collaborations or third-party manufacturing for this and other quality-driven tablets, helping us expand the reach of effective hepatoprotective solutions across the healthcare landscape.